Results 191 to 200 of about 52,325 (288)

Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments. [PDF]

open access: yesLancet Neurol
Pomirchy M   +4 more
europepmc   +1 more source

Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 856-866, May 2026.
The current study found no evidence of cumulative increased safety risks with upadacitinib 15 or 30 mg for up to 6 years and over 9000 patient‐years of safety data in adults and adolescents. There were low rates of adjudicated major adverse cardiovascular events, adjudicated thromboembolic events and malignancies. Abstract Background Atopic dermatitis (
Christopher G. Bunick   +13 more
wiley   +1 more source

Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. [PDF]

open access: yesClin Transl Sci
Mandecka A   +7 more
europepmc   +1 more source

Clinical Management of Herpes Zoster Complicated by MRSA Infection. [PDF]

open access: yesClin Cosmet Investig Dermatol
Chen X, Yu Q, Chang D, Sun L.
europepmc   +1 more source

Herpes zóster Simuladores que pueden desviar nuestra atención

open access: diamond, 2011
Gisela Vaglio Giors   +5 more
openalex   +2 more sources

Real‐World Use of Polynucleotide Injections in Scar Prevention and Management: A Nationwide Survey of Korean Society for Anti‐Aging Dermatology (KAAD) Dermatologists

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 5, May 2026.
ABSTRACT Background Scarring is a common dermatologic concern with both aesthetic and functional implications. Polynucleotide (PN)‐based injectables have emerged as medical devices in dermatologic practice; however, real‐world evidence on their use in scar management remains limited.
Nark Kyoung Rho   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy